These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1143488)
1. Proceedings: Covalent protein binding of norethisterone and norethisterone-4,5-epoxide in liver microsomes. Kappus H; Bolt HM Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R73. PubMed ID: 1143488 [No Abstract] [Full Text] [Related]
2. Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes. Kappus H; Remmer H Drug Metab Dispos; 1975; 3(5):338-44. PubMed ID: 241614 [TBL] [Abstract][Full Text] [Related]
4. Covalent interaction of metabolites of the carcinogen trichloroethylene in rat hepatic microsomes. Van Duuren BL; Banerjee S Cancer Res; 1976 Jul; 36(7 PT 1):2419-22. PubMed ID: 1277148 [TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Hinson JA; Pohl LR; Monks TJ; Gillette JR; Guengerich FP Drug Metab Dispos; 1980; 8(5):289-94. PubMed ID: 6107223 [TBL] [Abstract][Full Text] [Related]
6. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment. Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226 [TBL] [Abstract][Full Text] [Related]
7. Bromobenzene epoxidation leading to binding on macromolecular protein sites. Lau SS; Zannoni VG J Pharmacol Exp Ther; 1981 Nov; 219(2):563-72. PubMed ID: 7288634 [TBL] [Abstract][Full Text] [Related]
8. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins. Juedes MJ; Bulger WH; Kupfer D Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703 [TBL] [Abstract][Full Text] [Related]
9. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1). Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249 [TBL] [Abstract][Full Text] [Related]
10. The effect of paraquat on the covalent binding of radio-labelled DOPA to liver and lung microsomal protein [proceedings]. Davies DS; McManus ME Br J Pharmacol; 1979 Jul; 66(3):425P-426P. PubMed ID: 526715 [No Abstract] [Full Text] [Related]
11. Cytotoxic effects of norethindrone-4 beta,5 beta-epoxide to Walker cells in culture and to rat liver in vivo. White IN; Suzangar M Chem Biol Interact; 1980 Jun; 30(3):355-66. PubMed ID: 7379214 [TBL] [Abstract][Full Text] [Related]
12. Involvement of cytochrome P-450IIIA in metabolism of potassium canrenoate to an epoxide: mechanism of inhibition of the epoxide formation by spironolactone and its sulfur-containing metabolite. Cook CS; Hauswald C; Oppermann JA; Schoenhard GL J Pharmacol Exp Ther; 1993 Jul; 266(1):1-7. PubMed ID: 8331551 [TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of 16 alpha, 17 alpha-epoxy-oestratrienol in rat liver microsomes. Siekmann L; Thull P; Breuer H Acta Endocrinol (Copenh); 1980 Sep; 95(1):49-57. PubMed ID: 7456972 [TBL] [Abstract][Full Text] [Related]
14. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems. Fontaine SM; Mash EA; Hoyer PB; Sipes IG Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809 [TBL] [Abstract][Full Text] [Related]
15. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes. Yang SK; Bao ZP Mol Pharmacol; 1987 Jul; 32(1):73-80. PubMed ID: 3037304 [TBL] [Abstract][Full Text] [Related]
16. Regioselective and stereoselective metabolisms of pyrene and 1-bromopyrene by rat liver microsomes and effects of enzyme inducers. Shou M; Yang SK Drug Metab Dispos; 1988; 16(2):173-83. PubMed ID: 2898329 [TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins. Singh R; Silva Elipe MV; Pearson PG; Arison BH; Wong BK; White R; Yu X; Burgey CS; Lin JH; Baillie TA Chem Res Toxicol; 2003 Feb; 16(2):198-207. PubMed ID: 12588191 [TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of 4-vinylcyclohexene in rat and mouse liver, lung, and ovary. Keller DA; Carpenter SC; Cagen SZ; Reitman FA Toxicol Appl Pharmacol; 1997 May; 144(1):36-44. PubMed ID: 9169067 [TBL] [Abstract][Full Text] [Related]
19. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes. Pathiratne A; Puyear RL; Brammer JD Drug Metab Dispos; 1986; 14(4):386-91. PubMed ID: 2873983 [TBL] [Abstract][Full Text] [Related]
20. Covalent binding of polychlorinated biphenyls to rat liver microsomes in vitro: nature of reactive metabolites and target macromolecules. Shimada T; Sato R Toxicol Appl Pharmacol; 1980 Sep; 55(3):490-500. PubMed ID: 6776652 [No Abstract] [Full Text] [Related] [Next] [New Search]